Shenzhen Enmind Technology Co., Ltd. – Trademark Portfolio

Entity Type: 16

Shenzhen Enmind Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ENMIND. The owner is based in Shenzhen, Guangdong.

Room 201, Block A

No.1, Qianhai Road 1, Qianhaishen Port Cooperative District, Shenzhen

Shenzhen, Guangdong 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ENMIND
ENMIND
Registered 2019
Trademark
Serial #79267172
Registered 2019

Trademark Classifications

Shenzhen Enmind Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Enmind Technology Co., Ltd. have?

Shenzhen Enmind Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shenzhen Enmind Technology Co., Ltd. file in?

Shenzhen Enmind Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Enmind Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Enmind Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as ENMIND. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhen Enmind Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Enmind Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.